Starling Oncology director Brad Hively reports sale of 298,853 common shares worth $1.95 million

PUBT · 2d ago
Starling Oncology director Brad Hively reports sale of 298,853 common shares worth $1.95 million
  • Starling Oncology director Brad Hively sold 298,853 common shares on Aug. 21, 2026 at a weighted average USD 6.51.
  • Directly held stake fell to 411,976 shares following the transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Starling Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001079973-26-001175), on August 24, 2026, and is solely responsible for the information contained therein.